Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB
about
To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate RegulatorPreclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth.Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia.A toll-like receptor 2 pathway regulates the Ppargc1a/b metabolic co-activators in mice with Staphylococcal aureus sepsisAnimal Models Utilized in HTLV-1 ResearchMouse models with human immunity and their application in biomedical research.Osteolytic bone resorption in adult T-cell leukemia/lymphoma.Commensal microbiota contributes to chronic endocarditis in TAX1BP1 deficient mice.Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphomaAdult T cell leukemia lymphoma.Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo.Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway.Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia.HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathwaysAnimals Models of Human T Cell Leukemia Virus Type I Leukemogenesis.Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation.Critical role for TSLC1 expression in the growth and organ infiltration of adult T-cell leukemia cells in vivo.The state of the art in the pathogenesis of ATL and new potential targets associated with HTLV-1 and ATL.Current topics in prevention of human T-cell leukemia virus type i infection: NF-kappa B inhibitors and APOBEC3.Crucial role of carbonic anhydrase IX in tumorigenicity of xenotransplanted adult T-cell leukemia-derived cells.Animal models on HTLV-1 and related viruses: what did we learn?Molecular hallmarks of adult T cell leukemia.A20 targets caspase-8 and FADD to protect HTLV-I-infected cells.Superoxide-Generating Nox5α Is Functionally Required for the Human T-Cell Leukemia Virus Type 1-Induced Cell Transformation Phenotype.Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways.Lack of Oestrogenic Inhibition of the Nuclear Factor-κB Pathway in Somatolactotroph Tumour Cells.De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice.Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State.Route of primary HTLV-1 infection regulates HTLV-1 distribution in reservoir organs of infected mice.Aberrant overexpression of membrane-associated mucin contributes to tumor progression in adult T-cell leukemia/lymphoma cells.Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/γcnull mouse.A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity.Soy-derived isoflavones inhibit the growth of adult T-cell leukemia cells in vitro and in vivo.Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor.Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor-kappaB activity in unconditioned NOD/SCID/gammac(null) mice.
P2860
Q28386593-B1CA885A-4BBB-4B51-9790-73C4FD3543A0Q30377885-F70EC5B5-6238-4C85-BA5A-754E1EDB6A93Q33581506-85A0E36F-1527-4AF7-9C70-9D4740B0247AQ33779830-6A215860-CC49-4DE1-87A8-850A60F2CF99Q34038107-C0038562-30CE-4AFF-A4A3-D9F76DC92700Q34463104-F03D1FD7-72AB-4356-8B38-45D29A8C35C1Q34590684-5BFA451C-C4A9-4CD6-ABE7-53CF2C473F62Q34671504-A496B9F6-A591-4E1A-AA5D-AB40EA906B09Q35004711-D6131E4B-F514-4D87-8BA1-C6B3971EE447Q35138158-A46F1991-E103-4DEB-BC06-28DDBC1997C2Q35261245-4360CB86-A941-47AC-9523-0C48FC137E2EQ35750929-1A1D6703-12B2-442E-82DD-A41D1E21C396Q35880693-D90B221E-F6A6-439A-B00A-07CB304352C4Q35984815-2AF86E91-0B47-4419-B857-6D8F34234759Q36104480-EA72D455-029B-416B-A807-4357EF2EA0CAQ36147455-302221F4-A9EA-4C7D-8ADC-031AF01EC61FQ36254880-101063AA-CE59-4C9A-AEAD-61036A6F6BBBQ36311002-F30673B1-B895-4E69-8EB7-4B9603A50599Q36434903-DF21928D-0520-4BDA-8703-27684B21E465Q36751592-00A8369F-723D-441D-AF01-85CFC273F156Q36948607-23BD9C34-FEB6-425B-BD7C-19C870291A58Q36974728-4BFDA1AD-BE67-4808-97CE-18140543D9FBQ37008645-59913A01-7C73-40EC-A9C0-0E321F957555Q37198681-AACABD9C-CAFE-45BC-8CC7-C9599EA24FADQ37735639-8105A5C8-A0C7-4DD9-BA08-719C8DA2934EQ38050763-829D7460-9762-4162-8386-85B7909C3749Q38051633-00CAEEE0-4536-4D23-B1A5-2F4C5F45C8B1Q38830222-CD966C73-7953-4B74-8FF5-9A103A8C90D5Q38860291-A78FF7D3-3A15-4757-B41C-59F0BDAFAD68Q38862080-4D690011-3B47-4CD2-A676-461D3A687AA0Q38866445-3967FE2C-6716-4C3C-9755-68DFE2F0DB94Q39292402-61F9E7DD-FEF8-4465-8D73-192557FEC2F8Q39445928-D2359854-8E61-41CE-BAD6-955E467C24D0Q39508913-C6DBBA34-17DE-41D7-83EB-AA78167A91D5Q39539189-5BB9F8C5-0521-4714-BE18-84E23AB117B1Q39643234-4DF2C31D-FF9F-4F08-8A28-2C95C95F2123Q39777243-D89A1E3B-7B20-4BC6-A97E-9444C99F02C8Q40087963-642105DA-C928-494C-AEB3-EA4FAC704484Q40321775-CEA46CBD-D598-4D07-B4CC-EEFA0FB5A11FQ40383844-365EBD80-D0BF-4331-A5CA-CBE2168086E1
P2860
Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Rapid tumor formation of human ...... lines in novel NOD-SCID/gammac
@nl
Rapid tumor formation of human ...... an inhibitor against NF-kappaB
@ast
Rapid tumor formation of human ...... an inhibitor against NF-kappaB
@en
type
label
Rapid tumor formation of human ...... lines in novel NOD-SCID/gammac
@nl
Rapid tumor formation of human ...... an inhibitor against NF-kappaB
@ast
Rapid tumor formation of human ...... an inhibitor against NF-kappaB
@en
prefLabel
Rapid tumor formation of human ...... lines in novel NOD-SCID/gammac
@nl
Rapid tumor formation of human ...... an inhibitor against NF-kappaB
@ast
Rapid tumor formation of human ...... an inhibitor against NF-kappaB
@en
P2093
P2860
P1433
P1476
Rapid tumor formation of human ...... an inhibitor against NF-kappaB
@en
P2093
Akihiko Okayama
Hideki Hasegawa
Kazuo Terashima
M Zahidunnabi Dewan
Mamoru Ito
Masahiro Fujii
Michiyuki Maeda
Midori Taruishi
Naoki Mori
Yoko Kubuki
P2860
P304
P356
10.1128/JVI.77.9.5286-5294.2003
P407
P577
2003-05-01T00:00:00Z